Restless legs syndrome due to interferon
β
Jeffrey S. LaRochelle; Barbara I. Karp
π
Article
π
2004
π
John Wiley and Sons
π
English
β 47 KB
## Abstract A patient developed restless legs symptoms paralleling the course of interferonβΞ± (IFNΞ±) therapy for chronic hepatitis C. Symptoms began during a course of IFNΞ±, resolved with its suspension, and recurred on rechallenge. Restless legs syndrome may thus be an adverse effect of IFNΞ± treat